Donald Hayden
Voorzitter bij AVANIR PHARMACEUTICALS INC
Oorsprong van het eerstegraads netwerk van Donald Hayden
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 306 | |
| Public Company | Pharmaceuticals: Major | 44 | |
| Public Company | Pharmaceuticals: Major | 41 | |
| Subsidiary | Pharmaceuticals: Major | 26 | |
| Public Company | Pharmaceuticals: Major | 24 | |
| Subsidiary | Biotechnology | 16 | |
Transave, Inc.
 Transave, Inc. Pharmaceuticals: MajorHealth Technology Transave, Inc. is a biopharmaceutical company focused on developing innovative, inhaled pharmaceuticals for the site-specific treatment of serious lung diseases such as pulmonary infections in cystic fibrosis patients and cancers affecting the lung. They are committed to significantly improving the quality of life and healthcare of patients suffering from these life-threatening diseases. Its operating principles are centered on teamwork, openness, mutual respect, diversity of opinion, trust, accountability and innovative science. They are developing products based on Transave's proprietary liposomal technology designed specifically for lung delivery. Its focus is on reformulating off-patent, established drugs into unique liposomal technology - based inhaled pharmaceuticals for the localized, site-specific treatment of serious lung diseases. Transave's proprietary liposomal technology allows for the sustained release of a drug in the lung's microenvironment. By remaining in the lungs for a prolonged period and potentially minimizing systemic exposure, Transave's liposomal technology offers the potential for changing the product profile, improving delivery of the compound to the lung and enhancing the therapeutic index of established pharmaceuticals.
15
| Extinct | Pharmaceuticals: Major | 15 |
WindMIL Therapeutics, Inc.
 WindMIL Therapeutics, Inc. Medical SpecialtiesHealth Technology WindMIL Therapeutics, Inc. operates as a biotechnology company. It develops immunotherapies for the treatment of cancer patients. The company was founded by Ivan Borrello and Kimberly Noonan and is headquartered in Baltimore, MD.
11
| Holding Company | Medical Specialties | 11 |
| Subsidiary | Biotechnology | 9 | |
| Subsidiary | Pharmaceuticals: Major | 7 | |
Otsuka America Pharmaceutical, Inc.
 Otsuka America Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Otsuka America Pharmaceutical, Inc. manufactures and supplies pharmaceutical products. It develops drugs for neuroscience, cardiovascular, and gastrointestinal treatments. The company was founded in 1989 and is headquartered in Rockville, MD.
2
| Subsidiary | Pharmaceuticals: Major | 2 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Donald Hayden via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| Rutgers State University of New Jersey | College/University | Undergraduate Degree Masters Business Admin Masters Business Admin Corporate Officer/Principal Doctorate Degree Undergraduate Degree | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Chief Tech/Sci/R&D Officer Chief Operating Officer General Counsel Corporate Officer/Principal Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Sales & Marketing | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal General Counsel Corporate Officer/Principal Comptroller/Controller/Auditor | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
| GSK PLC | Pharmaceuticals: Major | Private Equity Analyst Corporate Officer/Principal Director/Board Member Director/Board Member | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Corporate Officer/Principal Chairman Director/Board Member Chairman | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Chairman Founder Chief Executive Officer Sales & Marketing | |
| NPS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member Corporate Secretary Compliance Officer | |
OrbiMed Advisors Private Equity
 OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London. | Investment Managers | Private Equity Investor Private Equity Investor Corporate Officer/Principal Private Equity Investor | |
| MEAD JOHNSON NUTRITION CO | Food: Meat/Fish/Dairy | Director/Board Member Director/Board Member Chairman Director/Board Member | |
Modis Therapeutics, Inc.
 Modis Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Modis Therapeutics, Inc. is a biopharmaceutical company, which develops disease-modifying therapies for rare genetic diseases. Its product MT1621 is in clinical development for thymidine kinase 2 deficiency (TK2d), an inherited mitochondrial disease. The company was founded by Peter H. Barber and Daniel D. DiPietro in 2016 and is headquartered in Oakland, CA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
Medarex, Inc.
 Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
| COMPASS PATHWAYS PLC | Biotechnology | Director/Board Member Director/Board Member Chief Executive Officer | |
| ARIAD PHARMACEUTICALS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Chief Administrative Officer Corporate Officer/Principal | |
| University of Pennsylvania | College/University | Undergraduate Degree Graduate Degree Doctorate Degree | |
| TOBIRA THERAPEUTICS INC | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO Corporate Secretary | |
| PORTOLA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Founder | |
European Federation of Pharmaceutical Industries & Assns
 European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
| Massachusetts Institute of Technology | College/University | Graduate Degree Doctorate Degree Graduate Degree | |
| Harvard College | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Medical/Nursing Services | Director/Board Member Director/Board Member Chairman | |
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Medical Specialties | Chief Tech/Sci/R&D Officer Chairman Chief Operating Officer | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| XILIO THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman President Director/Board Member | |
| CUBIST PHARMACEUTICALS INC | Pharmaceuticals: Major | Corporate Officer/Principal Chief Executive Officer Chief Administrative Officer | |
| Drexel University | College/University | Director/Board Member Masters Business Admin Undergraduate Degree | |
Allergan GI Corp.
 Allergan GI Corp. BiotechnologyHealth Technology Allergan GI Corp. develops peptide therapeutics for the treatment of gastrointestinal disorders. It provides RM-493 a small-peptide melanocortin-4 receptor agonist, for the treatment of obesity and diabetes, and RM-131 a small-peptide ghrelin agonist, for the treatment of diabetic gastro paresis and other gastrointestinal functional disorders. The company was founded by Bart Henderson and Elizabeth Stoner in 2008 and is headquartered in Madison, NJ. | Biotechnology | President Treasurer Corporate Secretary | |
BioNJ, Inc.
 BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services BioNJ, Inc. is based in Trenton, NJ. BioNJ, Inc. is a life sciences trade association with nearly 400 member companies. The company supports the discovery, development, and commercialization of therapies and cures that save and improve lives. BioNJ drives capital formation, fosters entrepreneurship, advocates for medical innovation, provides access to talent and education, and offers critical commercial resources. The company also serves as a clearinghouse for funding information and opportunities. The company was founded in 1994 by James J. Marino, Jayne C. Gershkowitz, Abraham Abuchowski. The CEO is Debbie Hart. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
Symbiomix Therapeutics LLC
 Symbiomix Therapeutics LLC BiotechnologyHealth Technology Symbiomix Therapeutics LLC develops medicines for women’s health infections and related diseases. It offers SYM-1219, a drug that contains secnidazole that facilitate administration as a single-dose oral therapy for various women's health infections including bacterial vaginosis. The company was founded by Jack Roberts, Steve Pomerantz and Joseph L. Amprey III in 2012 and is headquartered in Newark, NJ. | Biotechnology | Chief Tech/Sci/R&D Officer Director/Board Member Director/Board Member | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Chairman Director/Board Member Director/Board Member | |
| University of Massachusetts | College/University | Undergraduate Degree Director/Board Member Undergraduate Degree | |
| University of Oxford | College/University | Undergraduate Degree Doctorate Degree Graduate Degree | |
| Tufts University | College/University | Undergraduate Degree Chairman Undergraduate Degree | |
| ALLERGAN PLC | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal | |
The Business Roundtable
 The Business Roundtable Miscellaneous Commercial ServicesCommercial Services The Business Roundtable advocates public policies that ensure economic growth. It considers public policy issues which contains groups like the construction users anti-inflation roundtable, a group devoted to containing construction costs; and the labor law study committee, made up of labor relations executives of major companies. The Business Roundtable was founded in 1972 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| The Trustees of Columbia University in The City of New York | College/University | Corporate Officer/Principal Masters Business Admin | |
| European Round Table of Industrialists | Director/Board Member Corporate Officer/Principal | ||
| Villanova University | College/University | Undergraduate Degree Undergraduate Degree | |
| OXURION NV | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Sales & Marketing | |
| University of Vermont | College/University | Corporate Officer/Principal Undergraduate Degree | |
| AMERICAN EXPRESS COMPANY | Finance/Rental/Leasing | Director/Board Member Human Resources Officer | |
| SILENCE THERAPEUTICS PLC | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer | |
| RAYZEBIO, INC. | Biotechnology | Director/Board Member Director/Board Member | |
MBX Biosciences, Inc.
 MBX Biosciences, Inc. Electronic Equipment/InstrumentsElectronic Technology MBX Biosciences, Inc. operates as a preclinical-stage biotech company. It creates therapies to treat rare endocrine diseases. The company was founded by Peter Kent Hawryluk and Timothy Knickerbocker and is headquartered in Carmel, IN. | Electronic Equipment/Instruments | Director/Board Member Director/Board Member | |
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Thrombogenics, Inc.
 Thrombogenics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Oxurion NV, Thrombogenics, Inc. operates as a biotechnology company that delivers innovative treatments for diseases of the back of the eye, with a focus on diabetic eye disease. The company is based in New York, NY. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer Sales & Marketing | |
| NEUROPACE, INC. | Medical Specialties | Director/Board Member Director/Board Member |
Statistieken
Internationaal
| Verenigde Staten | 41 |
| Verenigd Koninkrijk | 6 |
| België | 4 |
| Frankrijk | 2 |
| Ierland | 2 |
Sectoraal
| Health Technology | 24 |
| Consumer Services | 13 |
| Commercial Services | 9 |
| Finance | 4 |
| Consumer Non-Durables | 2 |
Operationeel
| Director/Board Member | 707 |
| Independent Dir/Board Member | 231 |
| Corporate Officer/Principal | 227 |
| Chairman | 128 |
| Chief Executive Officer | 87 |
Sterkste connecties
| Insiders | |
|---|---|
| Carl Gordon | 59 |
| Annalisa Jenkins | 51 |
| James Topper | 49 |
| Argeris Karabelas | 42 |
| Myrtle Potter | 41 |
| Mark McDade | 35 |
| Georges Gemayel | 33 |
| Ambrose Bailey | 32 |
| Ted Love | 31 |
| Iain Dukes | 30 |
| Charles Newhall | 29 |
| Rishi Gupta | 29 |
| Charles Rowland | 25 |
| Elizabeth Anderson | 24 |
| Lamberto Andreotti | 23 |
- Beurs
- Insiders
- Donald Hayden
- Bedrijfsconnecties
